A polymer–lipid nanoparticle with a low molecular weight can preferentially deliver small interfering RNA to endothelial cells, offering an opportunity to treat many diseases.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Tabernero, J. et al. Cancer Discovery 3, 406–417 (2013).
Kanasty, R. et al. Nature Mater. 12, 967–977 (2013).
Coelho, T. et al. N. Engl. J. Med. 369, 819–829 (2013).
Dahlman, J. E. et al. Nature Nanotech. 9, 648–655 (2014).
Ganesh, S. et al. J. Control. Release 172, 699–706 (2013).
Fitzgerald, K. et al. Lancet 383, 60–68 (2014).
Kumar, V. et al. in Robbins and Cotran Pathologic Basis of Disease 8th edn (eds Schmitt, W. & Gruliow, R.) Ch. 11 (Saunders-Elsevier, 2009).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Clarke, D., McMillan, N. Cell-specific therapy on target. Nature Nanotech 9, 568–569 (2014). https://doi.org/10.1038/nnano.2014.155
Published:
Issue Date:
DOI: https://doi.org/10.1038/nnano.2014.155
This article is cited by
-
Enhanced Delivery of Plasmid Encoding Interleukin-12 Gene by Diethylene Triamine Penta-Acetic Acid (DTPA)-Conjugated PEI Nanoparticles
Applied Biochemistry and Biotechnology (2016)